Europe — EMA

Paclitaxel Ebewe

Request sourcing

Pack/s

What is Paclitaxel?

Paclitaxel, the active ingredient in Paclitaxel Ebewe, is a mitotic inhibitor presented as a sterile powder for intravenous infusion use. It treats various solid tumours and is administered in oncology patients. GNH USA supplies Paclitaxel Ebewe as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.

GNH USA supplies Paclitaxel Ebewe as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.

What is Paclitaxel used for?

Paclitaxel is used primarily for solid tumours that follow the micro‑cellular pathway.

- Breast cancer: improves the overall response rate and survival in patients with advanced disease. - Ovarian cancer: used as first‑line therapy in combination with carb ‑ cis or carboplatin. - Non‑small cell lung cancer : provides benef a the t t t t t t t t t t t t.

What are the side effects of Paclitaxel?

Paclit1 g

What precautions apply to Paclitaxel?

...

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →